We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$231M
AUM Growth
+$60.5M
Cap. Flow
+$101M
Cap. Flow %
43.67%
Top 10 Hldgs %
83.4%
Holding
32
New
10
Increased
8
Reduced
4
Closed
2

Sector Composition

Rank Sector Weight
1 Real Estate 28.86%
2 Healthcare 22.88%
3 Energy 8.73%
4 Communication Services 5.56%
5 Consumer Discretionary 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGP icon
1
CoStar Group
CSGP
$11.7B
$66.7M 28.86%
1,203,920
-130,800
-10% -$6.68M
URGN icon
2
UroGen Pharma
URGN
$1.86B
$30.3M 13.12%
843,365
+64,362
+8% +$2.37M
GLD icon
3
SPDR Gold Trust
GLD
$131B
$17.9M 7.76%
134,643
+132,043
+5,079% +$16.3M
SBR
4
Sabine Royalty Trust
SBR
$1.06B
$16.2M 6.99%
335,564
ALLO icon
5
Allogene Therapeutics
ALLO
$649M
$14.3M 6.18%
+532,166
New +$14.8M
META icon
6
Meta Platforms (Facebook)
META
$1.42T
$12.8M 5.56%
66,553
+24,500
+58% +$4.48M
BKNG icon
7
Booking.com
BKNG
$149B
$10.5M 4.55%
140,275
+23,750
+20% +$1.71M
LQD icon
8
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$9.58M 4.14%
77,237
+17,130
+28% +$2.06M
EMB icon
9
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$7.93M 3.43%
70,289
+13,558
+24% +$1.49M
HYG icon
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$6.48M 2.8%
74,648
-25,104
-25% -$2.17M
EDIT icon
11
Editas Medicine
EDIT
$396M
$4.59M 1.99%
185,668
MUB icon
12
iShares National Muni Bond ETF
MUB
$45.1B
$4.58M 1.98%
+40,600
New +$4.55M
CCJ icon
13
Cameco
CCJ
$37.6B
$4.01M 1.74%
+374,039
New +$4.03M
XLB icon
14
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$3.65M 1.58%
+1,117,400
New +$31.5M
TLT icon
15
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$3.4M 1.47%
25,630
+4,838
+23% +$614K
GSHD icon
16
Goosehead Insurance
GSHD
$2.2B
$3.32M 1.44%
+69,533
New +$2.42M
VYM icon
17
Vanguard High Dividend Yield ETF
VYM
$80.9B
$2.83M 1.22%
32,391
+105
+0.3% +$9.08K
PLYA
18
DELISTED
Playa Hotels & Resorts
PLYA
$2.31M 1%
300,000
GRTS
19
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$2.17M 0.94%
194,499
XLB icon
20
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$2.15M 0.93%
+579,600
New +$16.3M
UNG icon
21
PUT
United States Natural Gas Fund
UNG
$456M
$1.25M 0.54%
+133,600
New +$11.6M
BYND icon
22
CALL
Beyond Meat
BYND
$292M
$1.12M 0.48%
+27,072
New +$3.02M
SRNE
23
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.11M 0.48%
415,765
ENTX icon
24
Entera Bio
ENTX
$147M
$697K 0.3%
203,190
IBRX icon
25
ImmunityBio
IBRX
$7.51B
$568K 0.25%
556,453

Similar funds

Wildcat Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Wildcat Capital Management held 32 positions worth $231M, up 35% from $171M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Wildcat Capital Management deployed $101M of net new capital in Q2 2019, opening 10 new positions and adding to 8 existing holdings. Its largest new stake was Allogene Therapeutics: 532,166 shares worth $14.3M.

By sector, the portfolio is most concentrated in Real Estate at 29% of assets, down from 36% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was CoStar Group, an estimated $6.68M trimmed.

  • Wildcat Capital Management's largest Q2 2019 buy was Allogene Therapeutics: 532,166 shares worth $14.3M.
  • Wildcat Capital Management added most to SPDR Gold Trust in Q2 2019, an estimated $16.3M increase.
  • Wildcat Capital Management's biggest Q2 2019 reduction was CoStar Group, cutting an estimated $6.68M.
  • Wildcat Capital Management fully exited LPL Financial in Q2 2019, selling an estimated $7.08M.
  • Wildcat Capital Management's ten largest holdings make up 83% of its $231M portfolio in Q2 2019.
  • Wildcat Capital Management opened 10 new positions and closed 2 in Q2 2019.
  • Wildcat Capital Management's portfolio value rose 35% quarter-over-quarter to $231M.

Based on Wildcat Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.